Approximately one-third of people with chronic Trypanosoma cruzi infection develop
Chagas cardiomyopathy, which carries a poor prognosis. Accurate prediction of which …

Chagas disease is among the 21 neglected diseases according to the World Health
Organization. This study aimed to investigate the morbidity and mortality distribution of …

INTRODUCTION: Patients with Chagas disease (CD), caused by Trypanosoma cruzi,
present a higher risk of developing other chronic diseases, which may contribute to CD …

Background Chagas disease (CD) is still an important public health issue in Latin America.
This study aims to analyse the association between socio-epidemiological factors and …

INTRODUCTION We aimed to describe the sociodemographic, epidemiological, and clinical
characteristics of patients with chronic Chagas disease (CD) at an infectious disease referral …

The aims of this study were to estimate the prevalence of gastrointestinal manifestations
among individuals with positive serology for Chagas disease (ChD) and to describe the …

Chagas disease, caused by the parasite Trypanosoma cruzi, occurs most commonly in Latin
America. As the treatment is highly toxic and ineffective in the chronic phase of the disease …

Background and purpose Chagas disease and ischemic stroke (IS) have a close but poorly
understood correlation. In endemic settings, continued transmission over time has resulted …

Trypanosoma cruzi is a parasitic protozoan that infects a diversity of hosts constituting the
cycle of enzootic transmission in wild environments and causing disease in humans …

The etiological agent of Chagas disease is the protozoan Trypanosoma cruzi. According to
the World Health Organization, about seven to eight million people are infected with T. cruzi …